These results suggest that PD-L1 expression was induced by IFN-γ, and raises the possibility of dual therapy using IFN-γ and PD-L1 for pleomorphic rhabdomyosarcoma, DDLPS, myxoid liposarcoma, and rhabdomyosarcoma. The gene discussed is IFNG; the disease is myxoid liposarcoma.